# Association of MMP9 and NOS3 Polymorphisms with Distinct Clinical Forms of Juvenile Scleroderma and Characteristics of Humoral Immunity

**Authors:** Maria Osminina, Vera Podzolkova, Maria Litvinova, Natalia Geppe, Svetlana Chebysheva, Lusine Khachatryan, Natalia Golovanova, Yulia Kostina, Oksana Lazareva-Batyreva, Angelina Polyanskaya, Olga Shpitonkova, Tatiana Subbotina, Tigran Areian, Nadezhda Podchernyaeva

PMC · DOI: 10.3390/ijms27021109 · 2026-01-22

## TL;DR

This study explores how genetic variations in MMP9 and NOS3 genes are linked to different types of juvenile scleroderma and immune system traits.

## Contribution

The study identifies specific genetic polymorphisms associated with distinct clinical forms of juvenile scleroderma.

## Key findings

- The MMP9 CT genotype is significantly associated with localized juvenile scleroderma.
- The NOS3 GG genotype shows a trend toward association with systemic juvenile scleroderma.
- The NOS3 GG genotype correlates with lower levels of anti-collagen IV antibodies.

## Abstract

Juvenile scleroderma (JS), comprising localized (JLSd) and systemic (JSSc) forms, is a rare autoimmune disorder. This study investigated associations of polymorphisms in extracellular matrix (MMP1, MMP9) and vascular homeostasis (NOS3) genes with JS risk and immunological phenotypes. A case–control study involved 215JS patients (194 JLSd, 21 JSSc) and 72 controls. SNPs (MMP1 rs1799750, MMP9 rs3918242, NOS3 rs1799983) were genotyped using real-time PCR followed by minisequencing and mass spectrometric analysis of reaction products. Associations with disease risk, subtypes, and immunological markers were analyzed statistically. The MMP9 (rs3918242) CT genotype was significantly associated with JLSd (OR = 2.23, 95% CI: 1.14–4.37, p = 0.022), showing a trend in linear facial forms. The NOS3 (rs1799983) GG genotype demonstrated a trend toward association with JSSc (OR = 2.61, 95% CI: 0.92–7.37, p = 0.065). No significant associations were found for rs1799750 MMP1 and risk of disease development. The MMP9 risk genotype did not correlate with scleroderma-specific autoantibodies, while the NOS3 GG genotype was associated with lower serum levels of anti-collagen IV antibodies (p = 0.039). Genetic associations differ for JS subtypes: MMP9 with JLSd and NOS3 with JSSc. Children with CT polymorphism MMP9 (rs3918242) and with NOS3 (rs1799983) GG genotype were found to be genetically predisposed for the development of JS.

## Linked entities

- **Genes:** MMP1 (matrix metallopeptidase 1) [NCBI Gene 4312], MMP9 (matrix metallopeptidase 9) [NCBI Gene 4318], NOS3 (nitric oxide synthase 3) [NCBI Gene 4846]

## Full-text entities

- **Genes:** MMP9 (matrix metallopeptidase 9) [NCBI Gene 4318] {aka CLG4B, GELB, MANDP2, MMP-9}, NOS3 (nitric oxide synthase 3) [NCBI Gene 4846] {aka EC-NOS, ECNOS, MYMY8, NOSIII, cNOS, eNOS}, MMP1 (matrix metallopeptidase 1) [NCBI Gene 4312] {aka CLG}
- **Diseases:** JS (MESH:C543759), scleroderma (MESH:D012595), autoimmune disorder (MESH:D001327)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** rs1799983, rs3918242, rs1799750

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12841920/full.md

---
Source: https://tomesphere.com/paper/PMC12841920